首页 > 市场调查报告书 > 製药

奈米技术 DDS

市场调查报告书

商品编码

1339257

奈米医学市场、份额、规模、趋势、行业分析报告：按应用、按适应症、按分子类型、按地区、按细分市场、预测，2023-2032 年

Nanomedicine Market Share, Size, Trends, Industry Analysis Report, By Application (Drug Delivery), By Indication (Clinical Oncology, Infectious Diseases), By Molecule Type, By Region, And Segment Forecasts, 2023 - 2032

出版日期: 2023年07月23日 | 出版商:

Polaris Market Research | 英文 114 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录图表

根据Polaris Market Research的最新研究，到2032年，全球奈米医学市场预计将达到5,377.5亿美元。该报告提供了对当前市场动态的详细见解，并对未来市场成长进行了分析。

癌症和心血管疾病等慢性疾病的流行正在推动奈米药物的需求。随着人口老化以及高血压和肥胖等疾病患者数量的增加，对创新和有针对性的治疗方法的需求也随之增加。例如，美国癌症协会估计，2022 年仅美国就会新增 190 万癌症病例，并有 609,360 例癌症相关死亡。这凸显了迫切需要包括奈米医学在内的先进治疗方法来应对这些医疗保健挑战。

奈米医学能够实现标靶药物输送、改进的影像技术和个人化医疗方法，以改善治疗结果。新药物输送技术的出现也促进了奈米医学产业的扩张。奈米颗粒、奈米载体和其他奈米级药物传输系统具有提高生物利用度、控制释放和减少副作用等优点。药物传输技术的这些进步吸引了製药公司和医疗保健提供者的注意和投资。

政府的资助和支持对于推动奈米医学市场至关重要。世界各国政府已经认识到奈米医学彻底改变医疗保健的潜力，并正在提供财政支持、研究资助和监管支持，以加速奈米医学产品的开发和商业化。增加政府资助和支持措施预计将促进学术界、工业界和研究机构之间的合作，从而对市场成长产生积极影响。例如，2022年8月，韩国生命科学基金宣布对Senda Biosciences投资超过1,400万美元。此类投资代表了充满希望的成长机会，并显示了对奈米医学产业未来的信心。

过去几十年来，美国食品和药物管理局 (FDA) 批准了大约 100 种奈米医学应用和设备，极大地激发了人们对奈米技术医疗潜力日益增长的兴趣。监管机构的这项验证增强了人们对奈米医学的信心，并刺激了该领域的进一步投资、研究和开发。人们越来越认识到奈米技术在推进医学治疗和疗法中的作用，这被认为是医学领域的突破，也是市场成长的驱动力。

奈米医学市场报告亮点

现代贸易通路产业预计在预测期内将以大幅复合年增长率成长，因为它包括杂货连锁店、小型超市和大卖场等主要参与者。

体育用品商店占收入的最大份额，这是由于体育用品商店中各种雪地摩托车的供应量不断增加而推动的。

由于雪上运动活动的增加以及雪地摩托车的发展，预计亚太地区在预测期内将以显着的复合年增长率增长。

主要发现
简介
- 2019-2032 年奈米药物市场评估（按地区）
奈米医学市场 - 北美
- 北美：以适应症划分的奈米医学市场，2019-2032 年
- 北美：按分子类型划分的奈米医学市场，2019-2032 年
- 北美：奈米医学市场，按应用划分，2019-2032 年
- 美国奈米医学市场
- 奈米医学市场 - 加拿大
奈米医学市场 - 欧洲
- 欧洲：奈米医学市场，依适应症划分，2019-2032 年
- 欧洲：奈米医学市场，依分子类型，2019-2032 年
- 欧洲：奈米医学市场，依应用划分，2019-2032 年
- 奈米医学市场 - 英国
- 奈米医学市场 - 法国
- 奈米医学市场 - 德国
- 奈米医学市场 - 义大利
- 奈米医学市场 - 西班牙
- 奈米医学市场 - 荷兰
- 奈米医学市场 - 俄罗斯
奈米医学市场 - 亚太地区
- 亚太地区：以适应症划分的奈米医学市场，2019-2032 年
- 亚太地区：奈米医学市场，依分子类型，2019-2032 年
- 亚太地区：奈米医学市场，按应用划分，2019-2032 年
- 奈米医学市场 - 中国
- 奈米医学市场—印度
- 奈米医学市场 - 马来西亚
- 奈米医学市场－日本
- 纳米医药市场－印度尼西亚
- 奈米医学市场－韩国
奈米医学市场 - 中东和非洲
- 中东与非洲：奈米医学市场，依适应症划分，2019-2032 年
- 中东和非洲：奈米医学市场，按分子类型，2019-2032 年
- 中东与非洲：奈米医学市场，按应用划分，2019-2032 年
- 奈米医学市场－沙乌地阿拉伯
- 奈米医学市场 - 阿拉伯联合大公国
- 奈米医学市场——以色列
- 奈米医学市场 - 南非
奈米医学市场 - 拉丁美洲
- 拉丁美洲：奈米医学市场，依适应症划分，2019-2032 年
- 拉丁美洲：奈米医学市场，依分子类型，2019-2032 年
- 拉丁美洲：奈米医学市场，按应用划分，2019-2032 年
- 奈米医学市场 - 墨西哥
- 奈米医学市场 - 巴西
- 奈米医学市场——阿根廷

第九章竞争态势

扩张与收购分析
- 放大
- 收购
伙伴关係/协作/协议/揭露

第十章公司简介

GE Healthcare
Abbott Laboratories
CombiMatrix Corporation
Celgene
Nanospectra Biosciences
Johnson & Johnson
Mallinckrodt Pharmaceuticals
Merck
Pfizer
Teva Pharmaceutical
Arrowhead Pharmaceuticals

简介目录图表

Product Code: PM3637

The global nanomedicine market size is expected to reach USD 537.75 billion by 2032, according to a new study by Polaris Market Research. The report "Nanomedicine Market Share, Size, Trends, Industry Analysis Report, By Application (Drug Delivery), By Indication (Clinical Oncology, Infectious Diseases), By Molecule Type, By Region, And Segment Forecasts, 2023 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The prevalence of chronic diseases, including cancer and cardiovascular diseases, is driving the demand for nanomedicine. With an aging population and an increase in patients with conditions such as high blood pressure and obesity, the need for innovative and targeted treatment approaches has become more critical. For example, according to the American Cancer Society, in 2022, it was estimated that there would be 1.9 million new cancer cases and 609,360 cancer-related deaths in the United States alone. This highlights the urgent need for advanced therapies, including nanomedicine, to address these healthcare challenges.

Nanomedicine enables targeted drug delivery, improved imaging techniques, and personalized medicine approaches, enhancing treatment outcomes. The emergence of novel drug-delivery technologies also contributes to the nanomedicine industry's expansion. Nanoparticles, nanocarriers, and other nanoscale drug delivery systems offer advantages such as improved bioavailability, controlled release, and reduced side effects. These advancements in drug delivery technology have attracted attention and investment from pharmaceutical companies and healthcare providers.

Government funding and support are crucial in driving the nanomedicine market forward. Governments worldwide recognize the potential of nanomedicine in revolutionizing healthcare and are providing financial assistance, research grants, and regulatory support to encourage the development and commercialization of nanomedicine products. The increase in government funding and support initiatives is anticipated to positively impact market growth, fostering collaboration between academia, industry, and research institutions. For instance, in August 2022, South Korea's Life Science Fund announced an investment of over USD 14 Mn in Senda Biosciences. Such investments indicate promising growth opportunities and signify confidence in the future of the nanomedicine industry.

The authorization of approximately 100 nanomedicine applications and devices by the US Food and Drug Administration (FDA) over the past few decades has significantly contributed to the increasing interest in nanotechnology's medical potential. This validation by regulatory authorities has boosted confidence in nanomedicine and stimulated further investment, research, and development in the field. The growing recognition of nanotechnology's role in advancing medical treatments and therapies is considered a breakthrough in the medical field, driving market growth.

Nanomedicine Market Report Highlights

The modern trade channels segment is anticipated to grow at a significant CAGR over the forecast period owing to they include bigger players like grocery chains, mini-marts, and hypermarkets.

Sports variety stores accounted for largest revenue share which is accelerated by the rising availability of various snow scooters in the sports stores.

Asia-Pacific is expected to grow at a considerable CAGR over the projected period on account of the rising snow sports activities as well as the development of snow scooters.

The global players include: Crayon Motors, Jiangsu Youmota Technology, NSG Products, Railz LLC, Shanghai Puyi Industrial, Lakeside Collection, Eretic Inc., and Wuxi Copower Technology.

Polaris Market Research has segmented the nanomedicine market report based on application, indication, molecule type, and region:

Nanomedicine, Application Outlook (Revenue - USD Billion, 2019 - 2032)

Therapeutics
In-vitro Diagnostics
Drug Delivery
In-vivo Imaging
Implants

Nanomedicine, Indication Outlook (Revenue - USD Billion, 2019 - 2032)

Clinical Oncology
Infectious Diseases
Clinical Cardiology
Orthopedics
Others

Nanomedicine, Molecule Type Outlook (Revenue - USD Billion, 2019 - 2032)

Nanoparticles
Metal & Metal Oxide Nanoparticles
Liposomes
Polymers & Polymer Drug Conjugates
Hydrogel Nanoparticles
Dendrimers
Inorganic Nanoparticles
Nanoshells
Nanotubes
Nanodevices

Nanomedicine, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
Russia
Netherlands
Asia Pacific
China
India
Japan
South Korea
Indonesia
Malaysia
Latin America
Argentina
Brazil
Mexico
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources

4. Global Nanomedicine Market Insights

4.1. Nanomedicine Market - Molecule Type Snapshot
4.2. Nanomedicine Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Increase in demand for renewable sources of energy
  - 4.2.1.2. Rise in demand for electricity consumption
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. High initial costs
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Nanomedicine Market Molecule Type Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis

5. Global Nanomedicine Market, by Indication

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Nanomedicine Market, by Indication, 2019-2032 (USD Billion)
5.3. Clinical Oncology
- 5.3.1. Global Nanomedicine Market, by Clinical Oncology, by Region, 2019-2032 (USD Billion)
5.4. Infectious diseases
- 5.4.1. Global Nanomedicine Market, by Infectious diseases, by Region, 2019-2032 (USD Billion)
5.5. Clinical Cardiology
- 5.5.1. Global Nanomedicine Market, by Clinical Cardiology, by Region, 2019-2032 (USD Billion)
5.6. Orthopedics
- 5.6.1. Global Nanomedicine Market, by Orthopedics, by Region, 2019-2032 (USD Billion)
5.7. Others
- 5.7.1. Global Nanomedicine Market, by Others, by Region, 2019-2032 (USD Billion)

6. Global Nanomedicine Market, by Application

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Nanomedicine Market, by Application, 2019-2032 (USD Billion)
6.3. Therapeutics
- 6.3.1. Global Nanomedicine Market, by Therapeutics, by Region, 2019-2032 (USD Billion)
6.4. in-vitro Diagnostics
- 6.4.1. Global Nanomedicine Market, by in-vitro Diagnostics, by Region, 2019-2032 (USD Billion)
6.5. Drug Delivery
- 6.5.1. Global Nanomedicine Market, by Drug Delivery, by Region, 2019-2032 (USD Billion)
6.6. In-vivo Imaging
- 6.6.1. Global Nanomedicine Market, by In-vivo Imaging, by Region, 2019-2032 (USD Billion)
6.7. Implants
- 6.7.1. Global Nanomedicine Market, by Implants, by Region, 2019-2032 (USD Billion)

7. Global Nanomedicine Market, by Molecule Type

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global Nanomedicine Market, by Molecule Type, 2019-2032 (USD Billion)
7.3. Nanoparticles
- 7.3.1. Global Nanomedicine Market, by Nanoparticles, By Region, 2019-2032 (USD Billion)
- 7.3.2. Metal & Metal Oxide Nanoparticles
  - 7.3.2.1. Global Nanomedicine Market, by Metal & Metal Oxide Nanoparticles, By Region, 2019-2032 (USD Billion)
- 7.3.3. Liposomes
  - 7.3.3.1. Global Nanomedicine Market, by Liposomes, By Region, 2019-2032 (USD Billion)
- 7.3.4. Polymers & polymer drug conjugates
  - 7.3.4.1. Global Nanomedicine Market, by Polymers & polymer drug conjugates, By Region, 2019-2032 (USD Billion)
- 7.3.5. Hydrogel Nanoparticles
  - 7.3.5.1. Global Nanomedicine Market, by Hydrogel Nanoparticles, By Region, 2019-2032 (USD Billion)
- 7.3.6. Dendrimers
  - 7.3.6.1. Global Nanomedicine Market, by Dendrimers, By Region, 2019-2032 (USD Billion)
- 7.3.7. Inorganic Nanoparticles
  - 7.3.7.1. Global Nanomedicine Market, by Inorganic Nanoparticles, By Region, 2019-2032 (USD Billion)
7.4. Nanoshells
- 7.4.1. Global Nanomedicine Market, by Nanoshells, By Region, 2019-2032 (USD Billion)
7.5. Nanotubes
- 7.5.1. Global Nanomedicine Market, by Nanotubes, By Region, 2019-2032 (USD Billion)
7.6. Nanodevices
- 7.6.1. Global Nanomedicine Market, by Nanodevices, By Region, 2019-2032 (USD Billion)

8. Global Nanomedicine Market, by Geography

8.1. Key findings
8.2. Introduction
- 8.2.1. Nanomedicine Market Assessment, By Geography, 2019-2032 (USD Billion)
8.3. Nanomedicine Market - North America
- 8.3.1. North America: Nanomedicine Market, by Indication, 2019-2032 (USD Billion)
- 8.3.2. North America: Nanomedicine Market, by Molecule Type, 2019-2032 (USD Billion)
- 8.3.3. North America: Nanomedicine Market, by Application, 2019-2032 (USD Billion)
- 8.3.4. Nanomedicine Market - U.S.
  - 8.3.4.1. U.S.: Nanomedicine Market, by Indication, 2019-2032 (USD Billion)
  - 8.3.4.2. U.S.: Nanomedicine Market, by Molecule Type, 2019-2032 (USD Billion)
  - 8.3.4.3. U.S.: Nanomedicine Market, by Application, 2019-2032 (USD Billion)
- 8.3.5. Nanomedicine Market - Canada
  - 8.3.5.1. Canada: Nanomedicine Market, by Indication, 2019-2032 (USD Billion)
  - 8.3.5.2. Canada.: Nanomedicine Market, by Molecule Type, 2019-2032 (USD Billion)
  - 8.3.5.3. Canada: Nanomedicine Market, by Application, 2019-2032 (USD Billion)
8.4. Nanomedicine Market - Europe
- 8.4.1. Europe: Nanomedicine Market, by Indication, 2019-2032 (USD Billion)
- 8.4.2. Europe.: Nanomedicine Market, by Molecule Type, 2019-2032 (USD Billion)
- 8.4.3. Europe: Nanomedicine Market, by Application, 2019-2032 (USD Billion)
- 8.4.4. Nanomedicine Market - UK
  - 8.4.4.1. UK: Nanomedicine Market, by Indication, 2019-2032 (USD Billion)
  - 8.4.4.2. UK.: Nanomedicine Market, by Molecule Type, 2019-2032 (USD Billion)
  - 8.4.4.3. UK: Nanomedicine Market, by Application, 2019-2032 (USD Billion)
- 8.4.5. Nanomedicine Market - France
  - 8.4.5.1. France: Nanomedicine Market, by Indication, 2019-2032 (USD Billion)
  - 8.4.5.2. France.: Nanomedicine Market, by Molecule Type, 2019-2032 (USD Billion)
  - 8.4.5.3. France: Nanomedicine Market, by Application, 2019-2032 (USD Billion)
- 8.4.6. Nanomedicine Market - Germany
  - 8.4.6.1. Germany: Nanomedicine Market, by Indication, 2019-2032 (USD Billion)
  - 8.4.6.2. Germany.: Nanomedicine Market, by Molecule Type, 2019-2032 (USD Billion)
  - 8.4.6.3. Germany: Nanomedicine Market, by Application, 2019-2032 (USD Billion)
- 8.4.7. Nanomedicine Market - Italy
  - 8.4.7.1. Italy: Nanomedicine Market, by Indication, 2019-2032 (USD Billion)
  - 8.4.7.2. Italy.: Nanomedicine Market, by Molecule Type, 2019-2032 (USD Billion)
  - 8.4.7.3. Italy: Nanomedicine Market, by Application, 2019-2032 (USD Billion)
- 8.4.8. Nanomedicine Market - Spain
  - 8.4.8.1. Spain: Nanomedicine Market, by Indication, 2019-2032 (USD Billion)
  - 8.4.8.2. Spain.: Nanomedicine Market, by Molecule Type, 2019-2032 (USD Billion)
  - 8.4.8.3. Spain: Nanomedicine Market, by Application, 2019-2032 (USD Billion)
- 8.4.9. Nanomedicine Market - Netherlands
  - 8.4.9.1. Netherlands: Nanomedicine Market, by Indication, 2019-2032 (USD Billion)
  - 8.4.9.2. Netherlands.: Nanomedicine Market, by Molecule Type, 2019-2032 (USD Billion)
  - 8.4.9.3. Netherlands: Nanomedicine Market, by Application, 2019-2032 (USD Billion)
- 8.4.10. Nanomedicine Market - Russia
  - 8.4.10.1. Russia: Nanomedicine Market, by Indication, 2019-2032 (USD Billion)
  - 8.4.10.2. Russia.: Nanomedicine Market, by Molecule Type, 2019-2032 (USD Billion)
  - 8.4.10.3. Russia: Nanomedicine Market, by Application, 2019-2032 (USD Billion)
8.5. Nanomedicine Market - Asia Pacific
- 8.5.1. Asia Pacific: Nanomedicine Market, by Indication, 2019-2032 (USD Billion)
- 8.5.2. Asia Pacific.: Nanomedicine Market, by Molecule Type, 2019-2032 (USD Billion)
- 8.5.3. Asia Pacific: Nanomedicine Market, by Application, 2019-2032 (USD Billion)
- 8.5.4. Nanomedicine Market - China
  - 8.5.4.1. China: Nanomedicine Market, by Indication, 2019-2032 (USD Billion)
  - 8.5.4.2. China.: Nanomedicine Market, by Molecule Type, 2019-2032 (USD Billion)
  - 8.5.4.3. China: Nanomedicine Market, by Application, 2019-2032 (USD Billion)
- 8.5.5. Nanomedicine Market - India
  - 8.5.5.1. India: Nanomedicine Market, by Indication, 2019-2032 (USD Billion)
  - 8.5.5.2. India.: Nanomedicine Market, by Molecule Type, 2019-2032 (USD Billion)
  - 8.5.5.3. India: Nanomedicine Market, by Application, 2019-2032 (USD Billion)
- 8.5.6. Nanomedicine Market - Malaysia
  - 8.5.6.1. Malaysia: Nanomedicine Market, by Indication, 2019-2032 (USD Billion)
  - 8.5.6.2. Malaysia.: Nanomedicine Market, by Molecule Type, 2019-2032 (USD Billion)
  - 8.5.6.3. Malaysia: Nanomedicine Market, by Application, 2019-2032 (USD Billion)
- 8.5.7. Nanomedicine Market - Japan
  - 8.5.7.1. Japan: Nanomedicine Market, by Indication, 2019-2032 (USD Billion)
  - 8.5.7.2. Japan.: Nanomedicine Market, by Molecule Type, 2019-2032 (USD Billion)
  - 8.5.7.3. Japan: Nanomedicine Market, by Application, 2019-2032 (USD Billion)
- 8.5.8. Nanomedicine Market - Indonesia
  - 8.5.8.1. Indonesia: Nanomedicine Market, by Indication, 2019-2032 (USD Billion)
  - 8.5.8.2. Indonesia.: Nanomedicine Market, by Molecule Type, 2019-2032 (USD Billion)
  - 8.5.8.3. Indonesia: Nanomedicine Market, by Application, 2019-2032 (USD Billion)
- 8.5.9. Nanomedicine Market - South Korea
  - 8.5.9.1. South Korea: Nanomedicine Market, by Indication, 2019-2032 (USD Billion)
  - 8.5.9.2. South Korea.: Nanomedicine Market, by Molecule Type, 2019-2032 (USD Billion)
  - 8.5.9.3. South Korea: Nanomedicine Market, by Application, 2019-2032 (USD Billion)
8.6. Nanomedicine Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Nanomedicine Market, by Indication, 2019-2032 (USD Billion)
- 8.6.2. Middle East & Africa.: Nanomedicine Market, by Molecule Type, 2019-2032 (USD Billion)
- 8.6.3. Middle East & Africa: Nanomedicine Market, by Application, 2019-2032 (USD Billion)
- 8.6.4. Nanomedicine Market - Saudi Arabia
  - 8.6.4.1. Saudi Arabia: Nanomedicine Market, by Indication, 2019-2032 (USD Billion)
  - 8.6.4.2. Saudi Arabia.: Nanomedicine Market, by Molecule Type, 2019-2032 (USD Billion)
  - 8.6.4.3. Saudi Arabia: Nanomedicine Market, by Application, 2019-2032 (USD Billion)
- 8.6.5. Nanomedicine Market - UAE
  - 8.6.5.1. UAE: Nanomedicine Market, by Indication, 2019-2032 (USD Billion)
  - 8.6.5.2. UAE.: Nanomedicine Market, by Molecule Type, 2019-2032 (USD Billion)
  - 8.6.5.3. UAE: Nanomedicine Market, by Application, 2019-2032 (USD Billion)
- 8.6.6. Nanomedicine Market - Israel
  - 8.6.6.1. Israel: Nanomedicine Market, by Indication, 2019-2032 (USD Billion)
  - 8.6.6.2. Israel.: Nanomedicine Market, by Molecule Type, 2019-2032 (USD Billion)
  - 8.6.6.3. Israel: Nanomedicine Market, by Application, 2019-2032 (USD Billion)
- 8.6.7. Nanomedicine Market - South Africa
  - 8.6.7.1. South Africa: Nanomedicine Market, by Indication, 2019-2032 (USD Billion)
  - 8.6.7.2. South Africa.: Nanomedicine Market, by Molecule Type, 2019-2032 (USD Billion)
  - 8.6.7.3. South Africa: Nanomedicine Market, by Application, 2019-2032 (USD Billion)
8.7. Nanomedicine Market - Latin America
- 8.7.1. Latin America: Nanomedicine Market, by Indication, 2019-2032 (USD Billion)
- 8.7.2. Latin America.: Nanomedicine Market, by Molecule Type, 2019-2032 (USD Billion)
- 8.7.3. Latin America: Nanomedicine Market, by Application, 2019-2032 (USD Billion)
- 8.7.4. Nanomedicine Market - Mexico
  - 8.7.4.1. Mexico: Nanomedicine Market, by Indication, 2019-2032 (USD Billion)
  - 8.7.4.2. Mexico.: Nanomedicine Market, by Molecule Type, 2019-2032 (USD Billion)
  - 8.7.4.3. Mexico: Nanomedicine Market, by Application, 2019-2032 (USD Billion)
- 8.7.5. Nanomedicine Market - Brazil
  - 8.7.5.1. Brazil: Nanomedicine Market, by Indication, 2019-2032 (USD Billion)
  - 8.7.5.2. Brazil.: Nanomedicine Market, by Molecule Type, 2019-2032 (USD Billion)
  - 8.7.5.3. Brazil: Nanomedicine Market, by Application, 2019-2032 (USD Billion)
- 8.7.6. Nanomedicine Market - Argentina
  - 8.7.6.1. Argentina: Nanomedicine Market, by Indication, 2019-2032 (USD Billion)
  - 8.7.6.2. Argentina.: Nanomedicine Market, by Molecule Type, 2019-2032 (USD Billion)
  - 8.7.6.3. Argentina: Nanomedicine Market, by Application, 2019-2032 (USD Billion)

9. Competitive Landscape

9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

10.1. GE Healthcare
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
10.2. Abbott Laboratories
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
10.3. CombiMatrix Corporation
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
10.4. Celgene
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
10.5. Nanospectra Biosciences
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
10.6. Johnson & Johnson
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
10.7. Mallinckrodt Pharmaceuticals
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
10.8. Merck
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
10.9. Pfizer
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
10.10. Teva Pharmaceutical
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development
10.11. Arrowhead Pharmaceuticals
- 10.11.1. Company Overview
- 10.11.2. Financial Performance
- 10.11.3. Product Benchmarking
- 10.11.4. Recent Development

简介目录图表

List of Tables

Table 1 Global Waste to Energy Market, by Waste Type, 2019-2032 (USD Billion)
Table 2 Global Waste to Energy Market, by Application, 2019-2032 (USD Billion)
Table 3 Global Waste to Energy Market, by Technology, 2019-2032 (USD Billion)
Table 4 Waste to Energy Market Assessment, By Geography, 2019-2032 (USD Billion)
Table 5 North America: Waste to Energy Market, by Waste Type, 2019-2032 (USD Billion)
Table 6 North America: Waste to Energy Market, by Application, 2019-2032 (USD Billion)
Table 7 North America: Waste to Energy Market, by Technology, 2019-2032 (USD Billion)
Table 8 U.S.: Waste to Energy Market, by Waste Type, 2019-2032 (USD Billion)
Table 9 U.S.: Waste to Energy Market, by Application, 2019-2032 (USD Billion)
Table 10 U.S.: Waste to Energy Market, by Technology, 2019-2032 (USD Billion)
Table 11 Canada: Waste to Energy Market, by Waste Type, 2019-2032 (USD Billion)
Table 12 Canada: Waste to Energy Market, by Application, 2019-2032 (USD Billion)
Table 13 Canada: Waste to Energy Market, by Technology, 2019-2032 (USD Billion)
Table 14 Europe: Waste to Energy Market, by Waste Type, 2019-2032 (USD Billion)
Table 15 Europe: Waste to Energy Market, by Application, 2019-2032 (USD Billion)
Table 16 Europe: Waste to Energy Market, by Technology, 2019-2032 (USD Billion)
Table 17 UK: Waste to Energy Market, by Waste Type, 2019-2032 (USD Billion)
Table 18 UK: Waste to Energy Market, by Application, 2019-2032 (USD Billion)
Table 19 UK: Waste to Energy Market, by Technology, 2019-2032 (USD Billion)
Table 20 France: Waste to Energy Market, by Waste Type, 2019-2032 (USD Billion)
Table 21 France: Waste to Energy Market, by Application, 2019-2032 (USD Billion)
Table 22 France: Waste to Energy Market, by Technology, 2019-2032 (USD Billion)
Table 23 Germany: Waste to Energy Market, by Waste Type, 2019-2032 (USD Billion)
Table 24 Germany: Waste to Energy Market, by Application, 2019-2032 (USD Billion)
Table 25 Germany: Waste to Energy Market, by Technology, 2019-2032 (USD Billion)
Table 26 Italy: Waste to Energy Market, by Waste Type, 2019-2032 (USD Billion)
Table 27 Italy: Waste to Energy Market, by Application, 2019-2032 (USD Billion)
Table 28 Italy: Waste to Energy Market, by Technology, 2019-2032 (USD Billion)
Table 29 Spain: Waste to Energy Market, by Waste Type, 2019-2032 (USD Billion)
Table 30 Spain: Waste to Energy Market, by Application, 2019-2032 (USD Billion)
Table 31 Spain: Waste to Energy Market, by Technology, 2019-2032 (USD Billion)
Table 32 Netherlands: Waste to Energy Market, by Waste Type, 2019-2032 (USD Billion)
Table 33 Netherlands: Waste to Energy Market, by Application, 2019-2032 (USD Billion)
Table 34 Netherlands: Waste to Energy Market, by Technology, 2019-2032 (USD Billion)
Table 35 Russia: Waste to Energy Market, by Waste Type, 2019-2032 (USD Billion)
Table 36 Russia: Waste to Energy Market, by Application, 2019-2032 (USD Billion)
Table 37 Russia: Waste to Energy Market, by Technology, 2019-2032 (USD Billion)
Table 38 Asia Pacific: Waste to Energy Market, by Waste Type, 2019-2032 (USD Billion)
Table 39 Asia Pacific: Waste to Energy Market, by Application, 2019-2032 (USD Billion)
Table 40 Asia Pacific: Waste to Energy Market, by Technology, 2019-2032 (USD Billion)
Table 41 China: Waste to Energy Market, by Waste Type, 2019-2032 (USD Billion)
Table 42 China: Waste to Energy Market, by Application, 2019-2032 (USD Billion)
Table 43 China: Waste to Energy Market, by Technology, 2019-2032 (USD Billion)
Table 44 India: Waste to Energy Market, by Waste Type, 2019-2032 (USD Billion)
Table 45 India: Waste to Energy Market, by Application, 2019-2032 (USD Billion)
Table 46 India: Waste to Energy Market, by Technology, 2019-2032 (USD Billion)
Table 47 Malaysia: Waste to Energy Market, by Waste Type, 2019-2032 (USD Billion)
Table 48 Malaysia: Waste to Energy Market, by Application, 2019-2032 (USD Billion)
Table 49 Malaysia: Waste to Energy Market, by Technology, 2019-2032 (USD Billion)
Table 50 Japan: Waste to Energy Market, by Waste Type, 2019-2032 (USD Billion)
Table 51 Japan: Waste to Energy Market, by Application, 2019-2032 (USD Billion)
Table 52 Japan: Waste to Energy Market, by Technology, 2019-2032 (USD Billion)
Table 53 Indonesia: Waste to Energy Market, by Waste Type, 2019-2032 (USD Billion)
Table 54 Indonesia: Waste to Energy Market, by Application, 2019-2032 (USD Billion)
Table 55 Indonesia: Waste to Energy Market, by Technology, 2019-2032 (USD Billion)
Table 56 South Korea: Waste to Energy Market, by Waste Type, 2019-2032 (USD Billion)
Table 57 South Korea: Waste to Energy Market, by Application, 2019-2032 (USD Billion)
Table 58 South Korea: Waste to Energy Market, by Technology, 2019-2032 (USD Billion)
Table 59 Middle East & Africa: Waste to Energy Market, by Waste Type, 2019-2032 (USD Billion)
Table 60 Middle East & Africa: Waste to Energy Market, by Application, 2019-2032 (USD Billion)
Table 61 Middle East & Africa: Waste to Energy Market, by Technology, 2019-2032 (USD Billion)
Table 62 Saudi Arabia: Waste to Energy Market, by Waste Type, 2019-2032 (USD Billion)
Table 63 Saudi Arabia: Waste to Energy Market, by Application, 2019-2032 (USD Billion)
Table 64 Saudi Arabia: Waste to Energy Market, by Technology, 2019-2032 (USD Billion)
Table 65 UAE: Waste to Energy Market, by Waste Type, 2019-2032 (USD Billion)
Table 66 UAE: Waste to Energy Market, by Application, 2019-2032 (USD Billion)
Table 67 UAE: Waste to Energy Market, by Technology, 2019-2032 (USD Billion)
Table 68 Israel: Waste to Energy Market, by Waste Type, 2019-2032 (USD Billion)
Table 69 Israel: Waste to Energy Market, by Application, 2019-2032 (USD Billion)
Table 70 Israel: Waste to Energy Market, by Technology, 2019-2032 (USD Billion)
Table 71 South Africa: Waste to Energy Market, by Waste Type, 2019-2032 (USD Billion)
Table 72 South Africa: Waste to Energy Market, by Application, 2019-2032 (USD Billion)
Table 73 South Africa: Waste to Energy Market, by Technology, 2019-2032 (USD Billion)
Table 74 Latin America: Waste to Energy Market, by Waste Type, 2019-2032 (USD Billion)
Table 75 Latin America: Waste to Energy Market, by Application, 2019-2032 (USD Billion)
Table 76 Latin America: Waste to Energy Market, by Technology, 2019-2032 (USD Billion)
Table 77 Mexico: Waste to Energy Market, by Waste Type, 2019-2032 (USD Billion)
Table 78 Mexico: Waste to Energy Market, by Application, 2019-2032 (USD Billion)
Table 79 Mexico: Waste to Energy Market, by Technology, 2019-2032 (USD Billion)
Table 80 Brazil: Waste to Energy Market, by Waste Type, 2019-2032 (USD Billion)
Table 81 Brazil: Waste to Energy Market, by Application, 2019-2032 (USD Billion)
Table 82 Brazil: Waste to Energy Market, by Technology, 2019-2032 (USD Billion)
Table 83 Argentina: Waste to Energy Market, by Waste Type, 2019-2032 (USD Billion)
Table 84 Argentina: Waste to Energy Market, by Application, 2019-2032 (USD Billion)
Table 85 Argentina: Waste to Energy Market, by Technology, 2019-2032 (USD Billion)

List of Figures

Figure 1. Global Waste to Energy Market, 2019-2032 (USD Billion)
Figure 2. Integrated Ecosystem
Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
Figure 4. Market by Geography
Figure 5. Porter's Five Forces
Figure 6. Market by Application
Figure 7. Global Waste to Energy Market, by Application, 2022 & 2032 (USD Billion)
Figure 8. Market by Waste Type
Figure 9. Global Waste to Energy Market, by Waste Type, 2022 & 2032 (USD Billion)
Figure 10. Market by Technology
Figure 11. Global Waste to Energy Market, by Technology, 2022 & 2032 (USD Billion)
Figure 12. Waste to Energy Market Assessment, By Geography, 2019-2032 (USD Billion)
Figure 13. Strategic Analysis - Waste to Energy Market